Stockscreener 앱 받기
92.27
1.98%
1.79
시장 영업 전:
91.79
-0.48
-0.52%
전일 마감가:
$90.48
열려 있는:
$90.48
하루 거래량:
4.17M
Relative Volume:
2.01
시가총액:
$20.34B
수익:
$7.68B
순이익/손실:
$903.80M
주가수익비율:
20.73
EPS:
4.45
순현금흐름:
$1.14B
1주 성능:
-10.23%
1개월 성능:
-14.04%
6개월 성능:
-16.25%
1년 성능:
-23.47%
1일 변동 폭
$90.09
$92.91
1주일 범위
$89.92
$103.27
52주 변동 폭
$89.92
$122.25
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.27 | 20.34B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
133.06 | 227.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.12 | 152.00B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.52 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.32 | 108.50B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.92 | 44.68B | 5.54B | 4.18B | 259.90M | 7.00 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Total Wrist Replacement Market Top Companies StudyZimmer - openPR.com
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer biomet updates 2025 guidance with eps range of $7.90-$8.10 amid product launches - MSN
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
Zimmer Biomet Holdings (NYSE:ZBH) Q1 Earnings Rise, Revises 2025 Revenue Guidance Upward - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Price Target Lowered by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet Holdings (ZBH) Maintains Outperform Rating Despite Price Target Cut | ZBH Stock News - GuruFocus
Morgan Stanley Adjusts Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet stock target cut to $100 by Bernstein SocGen - Investing.com UK
Zimmer Biomet Holdings (ZBH) Receives Target Price Adjustment from JP Morgan | ZBH Stock News - GuruFocus
UBS maintains sell on Zimmer Biomet stock, holds $105 target By Investing.com - Investing.com UK
Zimmer Biomet Holdings (ZBH) Target Price Lowered by Wells Fargo | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Stock Target Lowered as Challenges Weigh In - GuruFocus
Morgan Stanley Reduces Zimmer Biomet (ZBH) Price Target to $95 | - GuruFocus
Zimmer Biomet Holdings (ZBH) Target Price Adjusted by Baird Anal - GuruFocus
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Call Transcript - Insider Monkey
Zimmer Biomet (ZBH) Target Price Cut by Raymond James Amid Future Tariff Concerns | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Price Target Reduction Amid Q1 Updates - GuruFocus
Zimmer Biomet (ZBH) Price Target Revised by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Tariff Con - GuruFocus
Zimmer Biomet flags $60m-$80m tariff impact on 2025 profits - Yahoo Finance
Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet Q1 2025 net sales increase 1.1% to USD 1.909 bn - Medical Buyer
Zimmer Biomet Holdings First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Morgan Stanley cuts Zimmer Biomet stock target to $95 By Investing.com - Investing.com India
Zimmer Biomet expects $60M to $80M tariff impact this year - Yahoo Finance
Zimmer Biomet falls 10% after narrowing its 2025 EPS guidance range - MSN
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... By GuruFocus - Investing.com Canada
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Tariff Challenges - GuruFocus
Zimmer Biomet's Q1 earnings highlight strategic growth in orthopedic sector - Today's Medical Developments
Zimmer Biomet (ZBH) Shares Plummet 12% on Reduced Earnings Outlook - GuruFocus
Zimmer Biomet Reports Q1 2025 Financial Results - TipRanks
Zimmer: Q1 Earnings Snapshot - MySA
Earnings call transcript: Zimmer Biomet Q1 2025 sees stock fall despite earnings beat - Investing.com Nigeria
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MSN
Zimmer Biomet (ZBH) Faces Price Target Cut Amid Concerns Over Future Growth | ZBH Stock News - GuruFocus
U.S. Indexes Decreased Monday; Zimmer Biomet Holdings Took Biggest Hit - Barron's
Citi cuts Zimmer Biomet stock target to $104, retains neutral stance - Investing.com
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal - Benzinga
Zimmer Biomet stock target cut to $102 by Evercore ISI - Investing.com UK
Zimmer Biomet (ZBH) Price Target Reduced by RBC Capital | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Cut and Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer Biomet Seeks to Accelerate Knee Growth - Morningstar
Citi Adjusts Zimmer Biomet (ZBH) Price Target While Maintaining Neutral Stance | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Growth from Product Launches and Acquisition - GuruFocus
Citigroup Cuts Zimmer Biomet Price Target to $104 From $118 - marketscreener.com
Piper Sandler Cuts Zimmer Biomet Price Target to $100 From $105 - marketscreener.com
Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today - Yahoo Finance
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.05%
1.57%
자본화:
|
볼륨(24시간):